 Nigeria’s leading pharmaceutical company, May & Baker Nigeria Plc recorded impressive performance in the third quarter (Q3) as improving sales combined with increasingly efficient internal cost management lifted the bottomline by 44 per cent. Key highlights of the interim report and accounts of the company for the nine-month period ended September 30, 2020 submitted at…